查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944487

全球心臟定位市場：按類型、適應症、最終用戶、國家和地區分類－產業分析、市場規模、佔有率和預測（2025-2032年）

Cardiac Mapping Market, By Type, By Indication, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 331 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，心臟定位市場規模將達到 37.8912 億美元，從 2025 年到 2032 年，複合年成長率將達到 7.5%。

心臟定位是一種先進的電生理技術，使醫生能夠追蹤和研究心臟的電活動模式，並識別和治療心律不整。此過程包括將導管電極插入心臟，並收集電活動數據，從而繪製出心臟內異常電脈衝傳導的詳細圖譜。先進的心臟定位系統能夠產生2D和3D電解剖圖，使醫生能夠識別誘發心律不整的組織，並精確指導心導管電氣燒灼術治療，從而提高手術療效和患者預後。心臟定位是治療心房顫動、心房撲動和心室心搏過速的標準方法，也是現今微創心臟電生理手術的重要組成部分。

心臟定位市場動態

老化與心血管疾病（CVD）的增加

心臟定位市場正在擴張，主要受兩大因素驅動：人口老化和心血管疾病盛行率上升。隨著老齡化成長，心臟的結構和電生理變化使老年人更容易出現心律不整，例如心房顫動、心房撲動和心室心搏過速。高血壓、糖尿病、肥胖和缺乏運動等因素的增加，正成為全球心血管疾病的危險因素，導致越來越多的患者出現心律不整，需要全面的診斷和治療方案。隨著醫院和心臟護理中心尋求透過先進的心臟定位技術來提高診斷能力、治療效果和患者健康水平，對電生理手術的需求日益成長，尤其是利用心臟定位系統的心導管電氣燒灼術手術。

心臟定位市場：細分分析

按類型

預計到2024年，接觸式心臟定位系統將佔據最大的市場佔有率。這一成長主要歸因於因心臟異常入院治療的患者人數不斷增加，從而推動了全球對先進心臟定位系統的需求。隨著主要企業努力獲得其心臟定位系統的核准，預計該細分市場將繼續擴張。

心臟定位市場—區域分析

北美引領心臟標測產業。美國和加拿大憑藉心臟節律紊亂的高發病率、完善的心臟護理設施、現代化標測系統的全面應用以及眾多大型醫療設備製造商的存在，在市場上佔據市場領導地位，並顯著促進該地區乃至全球心臟定位市場的成長。

目錄

第1章心臟定位市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章心臟定位的關鍵市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章心臟定位市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章心臟定位市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章心臟定位市場概況

  • 心臟定位市場佔有率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章心臟定位市場（依類型分類）

  • 概述
    • 細分市場佔有率分析：按類型
    • 接觸式心臟定位系統
    • 非接觸式心臟定位系統

第8章 依適應症分類的心臟定位市場

  • 概述
    • 細分市場佔有率分析：依指標
    • 心房顫動（心房顫動）
    • 房室折返性心搏過速（AVRT）
    • 房室結折返性心搏過速（AVNRT）
    • 心房撲動
    • 心室性心搏過速（VT）
    • 室性早搏（PVC）
    • 其他

第9章心臟定位市場：依最終用戶分類

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 專科診所
    • 電生理檢查室
    • 醫院和門診手術中心（ASC）
    • 學術和研究機構
    • 其他

第10章 區域心臟定位市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第11章 主要供應商分析—心臟定位產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • GE HealthCare
    • Abbott Laboratories
    • Boston Scientific Corporation
    • Medtronic plc
    • MicroPort Scientific Corporation
    • EP Solutions SA
    • Acutus Medical
    • CathRx Ltd
    • Biosense Webster（Johnson &Johnson）
    • Siemens Healthineers
    • BIOTRONIK SE &Co. KG
    • Philips Healthcare
    • Lepu Medical Technology
    • Topera（Acquired by Abbott）
    • Stereotaxis Inc.
    • Bardy Diagnostics
    • CARTO（part of Biosense Webster）
    • Imricor Medical Systems
    • CardioFocus Inc.
    • APN Health, LLC

第12章：分析師視角360度分析

簡介目錄
Product Code: ANV6031

The Cardiac Mapping Market size was valued at US$3,789.12 Million in 2024, expanding at a CAGR of 7.5% from 2025 to 2032.

Cardiac mapping functions as an advanced electrophysiological method which enables doctors to track and study heart electrical patterns for the purpose of identifying and treating heart rhythm disorders. The process requires the insertion of catheter-based electrodes into the heart which they use to collect electrical data that produces detailed maps of abnormal electrical impulse propagation in the heart. Advanced cardiac mapping systems create two-dimensional and three-dimensional electro-anatomical maps which allow doctors to find arrhythmogenic tissue and direct catheter ablation treatments while enhancing their procedural effectiveness and patient results. Cardiac mapping functions as a standard method for treating atrial fibrillation and atrial flutter and ventricular tachycardia while serving as a vital component of current minimally invasive cardiac electrophysiology procedures.

Cardiac Mapping Market- Market Dynamics

Aging population and rising CVD burden

The cardiac mapping market experiences expansion because of two primary factors which include the increasing number of elderly people and the growing prevalence of cardiovascular diseases. The structural and electrical changes that occur in the heart because of aging make older adults more vulnerable to cardiac arrhythmias which include atrial fibrillation and atrial flutter and ventricular tachycardia. The global population experiences rising cardiovascular disease risk factors through increasing rates of hypertension and diabetes and obesity and lack of physical activity which results in more people developing rhythm disorders that need complete diagnostic and treatment solutions. The need for electrophysiology procedures is increasing especially for catheter ablation procedures which use cardiac mapping systems as hospitals and cardiac care centers seek to improve their diagnostic capabilities and procedure results and patient health through advanced cardiac mapping technologies.

Cardiac Mapping Market- Segmentation Analysis:

By Type

In 2024, the contact cardiac mapping systems segment holds the largest market share. The growth is due to increasing number of patient admissions for the treatment of heart abnormalities, which creates growing need for advanced cardiac mapping systems throughout the world. The segment will continue to expand because major companies now work to obtain approval for their cardiac mapping systems.

Cardiac Mapping Market- Geographical Insights

North America leads the industry. The United States and Canada exhibit market control because of their high occurrence of cardiac rhythm disorders and their established heart treatment facilities and their complete use of modern mapping systems and their presence of major medical equipment manufacturers. North America will keep its market leadership position through future years because of rising treatment numbers and continuous technological advancements and ongoing funding for electrophysiology development which will drive substantial growth in the cardiac mapping market throughout both regional and global markets.

Cardiac Mapping Market- Competitive Landscape:

The competitive landscape of the cardiac mapping market is led by a handful of large medtech firms that dominate through broad portfolios, global distribution, and heavy R&D investment-most notably Biosense Webster (Johnson & Johnson), Abbott, Boston Scientific, and Medtronic-while other established names (Philips, Siemens/GE partners, BIOTRONIK) and regional players (MicroPort, Lepu) fill out the field. The leading companies in the industry compete against each other by launching new mapping platforms and catheters which include 3D electro-anatomical systems and high-density/real-time mapping and integrated imaging and AI functionalities because these products create higher costs for customers who want to switch and they decrease the time products remain competitive in the market. A wave of smaller, fast-moving companies and startups (Acutus, Kardium, Biosig, Ablacon and others) develop niche advantages through their innovative sensor designs and signal-processing algorithms and affordable systems which drive established companies to develop new products and form partnerships and pursue targeted mergers and acquisitions.

Recent Developments:

In February 2025, Boston Scientific Corporation announced it has received CE mark for the navigation-enabled FARAWAVE(TM) NAV Ablation Catheter for the treatment of paroxysmal atrial fibrillation (AF) and for the new FARAVIEW(TM) Software. Both technologies will integrate and expand mapping option capabilities for cardiac ablation procedures using the FARAPULSE(TM) Pulsed Field Ablation (PFA) System, the most clinically proven PFA system for the treatment of AF, which has already benefited 200,000 patients globally. These technologies are compatible exclusively with the company's existing cardiac mapping technology and the company's latest offering, the OPAL HDx(TM) Mapping System.

In December 2025, Abbott announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt(TM) PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin commercial PFA cases in the United States and will continue its expansion of sites in the European Union following Volt CE Mark approval earlier this year.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CARDIAC MAPPING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GE HealthCare
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Medtronic plc
  • MicroPort Scientific Corporation
  • EP Solutions SA
  • Acutus Medical
  • CathRx Ltd
  • Biosense Webster (Johnson & Johnson)
  • Siemens Healthineers
  • BIOTRONIK SE & Co. KG
  • Philips Healthcare
  • Lepu Medical Technology
  • Topera (Acquired by Abbott)
  • Stereotaxis Inc.
  • Bardy Diagnostics
  • CARTO (part of Biosense Webster)
  • Imricor Medical Systems
  • CardioFocus Inc.
  • APN Health, LLC

GLOBAL CARDIAC MAPPING MARKET, BY TYPE - MARKET ANALYSIS, 2019 - 2032

  • Contact Cardiac Mapping Systems
  • Non-contact Cardiac Mapping Systems

GLOBAL CARDIAC MAPPING MARKET, BY INDICATION - MARKET ANALYSIS, 2019 - 2032

  • Atrial Fibrillation (AF)
  • Atrioventricular Reentrant Tachycardia (AVRT)
  • Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
  • Atrial Flutter
  • Ventricular Tachycardia (VT)
  • Premature Ventricular Contractions (PVCs)
  • Others

GLOBAL CARDIAC MAPPING MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Specialty Clinics
  • Electrophysiology (EP) Labs
  • Hospitals and ASCs
  • Academic & Research Institutes
  • Others

GLOBAL CARDIAC MAPPING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Cardiac Mapping Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Cardiac Mapping Market Snippet by Type
    • 2.1.2. Cardiac Mapping Market Snippet by Indication
    • 2.1.3. Cardiac Mapping Market Snippet by End User
    • 2.1.4. Cardiac Mapping Market Snippet by Country
    • 2.1.5. Cardiac Mapping Market Snippet by Region
  • 2.2. Competitive Insights

3. Cardiac Mapping Key Market Trends

  • 3.1. Cardiac Mapping Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Cardiac Mapping Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Cardiac Mapping Market Opportunities
  • 3.4. Cardiac Mapping Market Future Trends

4. Cardiac Mapping Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Cardiac Mapping Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Cardiac Mapping Market Landscape

  • 6.1. Cardiac Mapping Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Cardiac Mapping Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024&2032 (%)
    • 7.1.2. Contact Cardiac Mapping Systems
    • 7.1.3. Non-contact Cardiac Mapping Systems

8. Cardiac Mapping Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024&2032 (%)
    • 8.1.2. Atrial Fibrillation (AF)
    • 8.1.3. Atrioventricular Reentrant Tachycardia (AVRT)
    • 8.1.4. Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
    • 8.1.5. Atrial Flutter
    • 8.1.6. Ventricular Tachycardia (VT)
    • 8.1.7. Premature Ventricular Contractions (PVCs)
    • 8.1.8. Others

9. Cardiac Mapping Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024&2032 (%)
    • 9.1.2. Specialty Clinics
    • 9.1.3. Electrophysiology (EP) Labs
    • 9.1.4. Hospitals and ASCs
    • 9.1.5. Academic & Research Institutes
    • 9.1.6. Others

10. Cardiac Mapping Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Cardiac Mapping Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Cardiac Mapping Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.8.3. UK Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.8.4. UK Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.10.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.10.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.11.3. Spain Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.11.4. Spain Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.13.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.13.4. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.14.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.14.4. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.15.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.15.4. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Cardiac MappingKey Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.4.4. APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.4.5. APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.8.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.13.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.14.3. PhilippinesMarket Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. Cardiac Mapping Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.5.4. LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.5.5. LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. Cardiac MappingKey Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Billion)
    • 10.6.4. MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
    • 10.6.5. MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.8.3. UAE Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.8.4. UAE Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Billion)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Billion)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Billion)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Billion)

11. Key Vendor Analysis- Cardiac Mapping Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. GE HealthCare
    • 11.2.2. Abbott Laboratories
    • 11.2.3. Boston Scientific Corporation
    • 11.2.4. Medtronic plc
    • 11.2.5. MicroPort Scientific Corporation
    • 11.2.6. EP Solutions SA
    • 11.2.7. Acutus Medical
    • 11.2.8. CathRx Ltd
    • 11.2.9. Biosense Webster (Johnson & Johnson)
    • 11.2.10. Siemens Healthineers
    • 11.2.11. BIOTRONIK SE & Co. KG
    • 11.2.12. Philips Healthcare
    • 11.2.13. Lepu Medical Technology
    • 11.2.14. Topera (Acquired by Abbott)
    • 11.2.15. Stereotaxis Inc.
    • 11.2.16. Bardy Diagnostics
    • 11.2.17. CARTO (part of Biosense Webster)
    • 11.2.18. Imricor Medical Systems
    • 11.2.19. CardioFocus Inc.
    • 11.2.20. APN Health, LLC

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us